QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Vol. 19, Issue 10, 4141-4153, October 2008

This Article Full Text Full Text (PDF) Supplemental Materials All Versions of this Article: E07-12-1217v1 19/10/4141    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Sucharov, C. C. Articles by McKinsey, T. A. Search for Related Content PubMed PubMed Citation Articles by Sucharov, C. C. Articles by McKinsey, T. A.

YY1 Protects Cardiac Myocytes from Pathologic Hypertrophy by Interacting with HDAC5

Carmen C. Sucharov^*, Karen Dockstader^*, and Timothy A. McKinsey

*Division of Cardiology, School of Medicine, University of Colorado Health Sciences Center, Denver, CO 80262; and Gilead Colorado, Inc., Westminster, CO 80021

Submitted December 6, 2007; Revised May 27, 2008; Accepted June 26, 2008
Monitoring Editor: Sandra L. Schmid

YY1 is a transcription factor that can repress or activate the transcription of a variety of genes. Here, we show that the function of YY1 as a repressor in cardiac myocytes is tightly dependent on its ability to interact with histone deacetylase 5 (HDAC5). YY1 interacts with HDAC5, and overexpression of YY1 prevents HDAC5 nuclear export in response to hypertrophic stimuli and the increase in cell size and re-expression of fetal genes that accompany pathological cardiac hypertrophy. Knockdown of YY1 results in up-regulation of all genes present during fetal development and increases the cell size of neonatal cardiac myocytes. Moreover, overexpression of a YY1 deletion construct that does not interact with HDAC5 results in transcription activation, suggesting that HDAC5 is necessary for YY1 function as a transcription repressor. In support of this relationship, we show that knockdown of HDAC5 results in transcription activation by YY1. Finally, we show that YY1 interaction with HDAC5 is dependent on the HDAC5 phosphorylation domain and that overexpression of YY1 reduces HDAC5 phosphorylation in response to hypertrophic stimuli. Our results strongly suggest that YY1 functions as an antihypertrophic factor by preventing HDAC5 nuclear export and that up-regulation of YY1 in human heart failure may be a protective mechanism against pathological hypertrophy.

Address correspondence to: Carmen C. Sucharov (kika.sucharov{at}uchsc.edu)